CTHRC1 and metastatic malignant neoplasm in the lymph nodes: By analyzing the expression characteristics of CTHRC1 in the clinical EOC samples, we found that CTHRC1 levels in EOCs with lymph node metastasis were remarkably higher than those in EOCs without lymph node metastasis.